Objectively assessed physiological, physical, and cognitive function along with patient-reported outcomes during the first 2 years of Alemtuzumab treatment in multiple sclerosis: a prospective observational study

Lars G. Hvid*, Egon Stenager, Ulrik Dalgas

*Kontaktforfatter

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Fingeraftryk

Dyk ned i forskningsemnerne om 'Objectively assessed physiological, physical, and cognitive function along with patient-reported outcomes during the first 2 years of Alemtuzumab treatment in multiple sclerosis: a prospective observational study'. Sammen danner de et unikt fingeraftryk.

Medicine and Dentistry

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Psychology